Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL | NEJM

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL | NEJM

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

• Jennifer A. Woyach, M.D., 
• Amy S. Ruppert, Ph.D., 
• Nyla A. Heerema, Ph.D., 
• Weiqiang Zhao, M.D., 
• Allison M. Booth, M.S., 
• Wei Ding, M.B., B.S., Ph.D., 
• Nancy L. Bartlett, M.D., 
• Danielle M. Brander, M.D., 
• Paul M. Barr, M.D., 
• Kerry A. Rogers, M.D., 
• Sameer A. Parikh, M.B., B.S., 
• Steven Coutre, M.D.,